Brandt Kevin D's Form 4 filing
Xtant Medical Holdings, Inc.XTNT · filed Aug 17, 2022
- Accession no.
- 0001235802-22-000101
- Filed
- Aug 17, 2022, 5:28 PM ET
- Trade date
- Aug 15-17, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $11.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brandt Kevin DCIK 0001692661 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Common Stock, $0.000001 par value | AGrant or awardAcquired | +410,079 | $0.00 | $0 | 726,571 | Direct | |
| Aug 16, 2022 | Common Stock, $0.000001 par value | SSaleDisposed | −18,700 | $0.4905F4 | −$9,172.35 | 707,871 | Direct | |
| Aug 17, 2022 | Common Stock, $0.000001 par value | SSaleDisposed | −4,300 | $0.4766F5 | −$2,049.38 | 703,571 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.47161 to $0.52, inclusive. The reporting person undertakes to provide to Xtant Medical Holdings, Inc., any security holder of Xtant Medical Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.47 to $0.4953, inclusive. The reporting person undertakes to provide to Xtant Medical Holdings, Inc., any security holder of Xtant Medical Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.
Referenced by the price of 1 transaction in Table I.